RD2-molpack-chim3, a packaging cell line for stable production of lentiviral vectors for Anti-HIV gene therapy

Human Gene Therapy Methods

Volumn 24, Issue 4, 2013, Pages 228-240

  Stornaiuolo, Anna ^a   Piovani, Bianca Maria ^a   Bossi, Sergio ^a   Zucchelli, Eleonora ^a   Corna, Stefano ^a   Salvatori, Francesca ^a   Mavilio, Fulvio ^a   Bordignon, Claudio ^a   Rizzardi, Gian Paolo ^a   Bovolenta, Chiara ^a  

^a MOLMED S P A   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; LENTIVIRUS VECTOR; REV PROTEIN;

ARTICLE; DRUG MANUFACTURE; GENE EXPRESSION; GENETIC TRANSFECTION; HEMATOPOIETIC STEM CELL; LARGE SCALE PRODUCTION; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PSEUDOTYPING; VIRAL GENE DELIVERY SYSTEM; VIRUS ENVELOPE; VIRUS GENE;

ANIMALS; FUSION PROTEINS, GAG-POL; GENE PRODUCTS, REV; GENETIC THERAPY; GENETIC VECTORS; HEK293 CELLS; HEMATOPOIETIC STEM CELLS; HIV INFECTIONS; HUMANS; LENTIVIRUS; SF9 CELLS; SPODOPTERA; TRANSDUCTION, GENETIC; TRANSGENES; VIRUS ASSEMBLY;

EID: 84883002841     PISSN: 19466536     EISSN: 19466544     Source Type: Journal    
DOI: 10.1089/hgtb.2012.190     Document Type: Article

References (52)

1. Bahner, I., Sumiyoshi, T.,Kagoda, M., et al. (2007). Lentiviral vector transduction of a dominant-negative Rev gene into human CD34+ hematopoietic progenitor cells potently inhibits human immunodeficiency virus-1 replication. Mol. Ther. 15, 76-85. (Pubitemid 46043652)
2. Bestor, T.H. (2000). Gene silencing as a threat to the success of gene therapy. J. Clin. Invest. 105, 409-411. (Pubitemid 30127239)
3. Bovolenta, C., Porcellini, S., and Alberici, L. (2012). Therapeutic genes for Anti-HIV/AIDS Gene Therapy. Curr. Pharm. Biotechnol. [Epub ahead of print]
4. Brandtner, E.M., Kodajova, P., Knapp, E., et al. (2008). Quantification and characterization of autotransduction in retroviral vector producer cells. Hum. Gene Ther. 19, 97-102. (Pubitemid 351171369)
5. Broussau, S., Jabbour, N., Lachapelle, G., et al. (2008). Inducible packaging cells for large-scale production of lentiviral vectors in serum-free suspension culture. Mol. Ther. 16, 500-507. (Pubitemid 351314989)
6. Burns, J.C., Friedmann, T., Driever, W., et al. (1993). Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc. Natl. Acad. Sci. U. S. A. 90, 8033-8037. (Pubitemid 23260849)
7. Carroll, R., Lin, J.T., Dacquel, E.J., et al. (1994). A human immunodeficiency virus type 1 (HIV-1)-based retroviral vector system utilizing stable HIV-1 packaging cell lines. J. Virol. 68, 6047-6051. (Pubitemid 24258622)
8. Cheung, A.K., Hoggan, M.D., Hauswirth, W.W., and Berns, K.I. (1980). Integration of the adeno-associated virus genome into cellular DNA in latently infected human Detroit 6 cells. J. Virol. 33, 739-748. (Pubitemid 10176536)
9. Cockrell, A.S., Ma, H., Fu, K., et al. (2006). A trans-lentiviral packaging cell line for high-titer conditional self-inactivating HIV-1 vectors. Mol. Ther. 14, 276-284. (Pubitemid 43964495)
10. Corbeau, P., Kraus, G., and Wong-Staal, F. (1996). Efficient gene transfer by a human immunodeficiency virus type 1 (HIV-1)-derived vector utilizing a stable HIV packaging cell line. Proc. Natl. Acad. Sci. U. S. A. 93, 14070-14075.
11. Cornetta, K., Yao, J., Jasti, A., et al. (2011). Replication-competent lentivirus analysis of clinical grade vector products. Mol. Ther. 19, 557-566.
12. Di Nunzio, F., Piovani, B., Cosset, F.L., et al. (2007). Transduction of human hematopoietic stem cells by lentiviral vectors pseudotyped with the RD114-TR chimeric envelope glycoprotein. Hum. Gene Ther. 18, 811-820. (Pubitemid 47502847)
13. Farson, D.,Witt, R.,McGuinness,R., et al. (2001). A new-generation stable inducible packaging cell line for lentiviral vectors. Hum. Gene Ther. 12, 981-997. (Pubitemid 32681861)
14. Green, B.J., Lee, C.S., and Rasko, J.E. (2004). Biodistribution of the RD114/mammalian type D retrovirus receptor, RDR. J. Gene Med. 6, 249-259. (Pubitemid 40228042)
15. Hanawa, H., Persons, D.A., and Nienhuis, A.W. (2005). Mobilization and mechanism of transcription of integrated selfinactivating lentiviral vectors. J. Virol. 79, 8410-8421. (Pubitemid 40853543)
16. Ikeda, Y., Takeuchi, Y., Martin, F., et al. (2003). Continuous hightiter HIV-1 vector production. Nat. Biotechnol. 21, 569-572. (Pubitemid 36532025)
17. Kafri, T., Van Praag, H., Ouyang, L., et al. (1999). A packaging cell line for lentivirus vectors. J. Virol. 73, 576-584. (Pubitemid 28565401)
18. Kaplan, A.H., and Swanstrom, R. (1991). The HIV-1 gag precursor is processed via two pathways: implications for cytotoxicity. Biomed. Biochim. Acta 50, 647-653.
19. Kaul, M., Yu, H., Ron, Y., and Dougherty, J.P. (1998). Regulated lentiviral packaging cell line devoid of most viral cis-acting sequences. Virology 249, 167-174. (Pubitemid 28430918)
20. Kim, Y.S., Wielgosz, M.M., Hargrove, P., et al. (2010). Transduction of human primitive repopulating hematopoietic cells with lentiviral vectors pseudotyped with various envelope proteins. Mol. Ther. 18, 1310-1317.
21. Kitchen, S.G., Shimizu, S., and An, D.S. (2011). Stem cell-based anti-HIV gene therapy. Virology 411, 260-272.
22. Klages, N., Zufferey, R., and Trono, D. (2000). A stable system for the high-titer production of multiply attenuated lentiviral vectors. Mol. Ther. 2, 170-176.
23. Kotin, R.M., Siniscalco, M., Samulski, R.J., et al. (1990). Sitespecific integration by adeno-associated virus. Proc. Natl. Acad. Sci. U. S. A. 87, 2211-2215.
24. Kotin, R.M., Menninger, J.C., Ward, D.C., and Berns, K.I. (1991). Mapping and direct visualization of a region-specific viral DNA integration site on chromosome 19q13-qter. Genomics 10, 831-834.
25. Kotin, R.M., Linden, R.M., and Berns, K.I. (1992). Characterization of a preferred site on human chromosome 19q for integration of adeno-associated virus DNA by non-homologous recombination. EMBO J. 11, 5071-5078. (Pubitemid 23023451)
26. Krausslich, H.G. (1992). Specific inhibitor of human immunodeficiency virus proteinase prevents the cytotoxic effects of a single-chain proteinase dimer and restores particle formation. J. Virol. 66, 567-572.
27. Krausslich, H.G., Ochsenbauer, C., Traenckner, A.M., et al. (1993). Analysis of protein expression and virus-like particle formation in mammalian cell lines stably expressing HIV-1 gag and env gene products with or without active HIV proteinase. Virology 192, 605-617.
28. Laakso, M.M., and Sutton, R.E. (2006). Replicative fidelity of lentiviral vectors produced by transient transfection. Virology 348, 406-417.
29. Lamartina, S., Sporeno, E., Fattori, E., and Toniatti, C. (2000). Characteristics of the adeno-associated virus preintegration site in human chromosome 19: open chromatin conformation and transcription-competent environment. J. Virol. 74, 7671-7677. (Pubitemid 30613116)
30. Maruggi, G., Porcellini, S., Facchini, G., et al. (2009). Transcriptional enhancers induce insertional gene deregulation independently from the vector type and design. Mol. Ther. 17, 851-856.
31. Mitsuyasu, R.T., Zack, J.A., MacPherson, J.L., and Symonds, G.P. (2011). Phase I/II clinical trials using gene-modified adult hematopoietic stem cells for HIV: lessons learnt. Stem Cells Int. 2011, 393698.
32. Musatov, S.A., Dudus, L., Parrish, C.M., et al. (2002). Spontaneous mobilization of integrated recombinant adenoassociated virus in a cell culture model of virus latency. Virology 294, 151-169. (Pubitemid 34921298)
33. Nakai, H., Iwaki, Y., Kay, M.A., and Couto, L.B. (1999). Isolation of recombinant adeno-associated virus vector-cellular DNA junctions from mouse liver. J. Virol. 73, 5438-5447. (Pubitemid 29274826)
34. Neff, T., Peterson, L.J., Morris, J.C., et al. (2004). Efficient gene transfer to hematopoietic repopulating cells using concentrated RD114-pseudotype vectors produced by human packaging cells. Mol. Ther. 9, 157-159. (Pubitemid 38256541)
35. Ni, Y., Sun, S., Oparaocha, I., et al. (2005). Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector. J. Gene Med. 7, 818-834. (Pubitemid 40872867)
36. Pacchia, A.L., Adelson, M.E., Kaul, M., et al. (2001). An inducible packaging cell system for safe, efficient lentiviral vector production in the absence of HIV-1 accessory proteins. Virology 282, 77-86. (Pubitemid 32881777)
37. Poeschla, E., Corbeau, P., and Wong-Staal, F. (1996). Development of HIV vectors for anti-HIV gene therapy. Proc. Natl. Acad. Sci. U. S. A. 93, 11395-11399. (Pubitemid 26347132)
38. Porcellini, S., Alberici, L., Gubinelli, F., et al. (2009). The F12-Vif derivative Chim3 inhibits HIV-1 replication in CD4+ T lymphocytes and CD34 +-derived macrophages by blocking HIV-1 DNA integration. Blood 113, 3443-3452.
39. Porcellini, S., Gubinelli, F., Alberici, L., et al. (2010). Chim3 confers survival advantage to CD4 + T cells upon HIV-1 infection by preventing HIV-1 DNA integration and HIV-1-induced G2 cell-cycle delay. Blood 115, 4021-4029.
40. Recchia, A., Perani, L., Sartori, D., et al. (2004). Site-specific integration of functional transgenes into the human genome by adeno/AAV hybrid vectors. Mol. Ther. 10, 660-670. (Pubitemid 39272855)
41. Samulski, R.J., Chang, L.S., and Shenk, T. (1987). A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication. J. Virol. 61, 3096-3101. (Pubitemid 17131491)
42. Sandrin, V., Boson, B., Salmon, P., et al. (2002). Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34 + cells derived from human and nonhuman primates. Blood 100, 823-832. (Pubitemid 34832607)
43. Sandrin, V., Muriaux, D., Darlix, J.L., and Cosset, F.L. (2004). Intracellular trafficking of Gag and Env proteins and their interactions modulate pseudotyping of retroviruses. J. Virol. 78, 7153-7164. (Pubitemid 38781554)
44. Snasel, J., Shoeman, R., Horejsi, M., et al. (2000). Cleavage of vimentin by different retroviral proteases. Arch. Biochem. Biophys. 377, 241-245. (Pubitemid 30331884)
45. Sparacio, S., Pfeiffer, T., Schaal, H., and Bosch, V. (2001). Generation of a flexible cell line with regulatable, high-level expression of HIV Gag/Pol particles capable of packaging HIV-derived vectors. Mol. Ther. 3, 602-612. (Pubitemid 32509855)
46. Srinivasakumar, N., Chazal, N., Helga-Maria, C., et al. (1997). The effect of viral regulatory protein expression on gene delivery by human immunodeficiency virus type 1 vectors produced in stable packaging cell lines. J. Virol. 71, 5841-5848. (Pubitemid 27304920)
47. Strang, B.L., Ikeda, Y., Cosset, F.L., et al. (2004). Characterization of HIV-1 vectors with gammaretrovirus envelope glycoproteins produced from stable packaging cells. Gene Ther. 11, 591-598. (Pubitemid 38455977)
48. Throm, R.E., Ouma, A.A., Zhou, S., et al. (2009). Efficient construction of producer cell lines for a SIN lentiviral vector for SCID-X1 gene therapy by concatemeric array transfection. Blood 113, 5104-5110.
49. Trobridge, G.D., Wu, R.A., Hansen, M., et al. (2010). Cocalpseudotyped lentiviral vectors resist inactivation by human serum and efficiently transduce primate hematopoietic repopulating cells. Mol. Ther. 18, 725-733.
50. Vogt, B., Roscher, S., Abel, B., et al. (2001). Lack of superinfection interference in retroviral vector producer cells. Hum. Gene Ther. 12, 359-365. (Pubitemid 32186648)
51. Xu, K., Ma, H., McCown, T.J., et al. (2001). Generation of a stable cell line producing high-titer self-inactivating lentiviral vectors. Mol. Ther. 3, 97-104. (Pubitemid 32509810)
52. Yu, H., Rabson, A.B., Kaul, M., et al. (1996). Inducible human immunodeficiency virus type 1 packaging cell lines. J. Virol. 70, 4530-4537. (Pubitemid 26187451)